Data provision of PIK3CA gene diversity and recombinant plasmids preparation for control DNA in developing the trastuzumab predictive response diagnostic kit
Desriani, Budiarto BR, Harahap WA, Warisman MA,Ompusunggu AVC, Athariah D, Mirnawati F, Sriyani IY, Alahwani F, Kurniawan AR. 2016. Data provision of PIK3CA gene diversity and recombinant plasmids preparation for control DNA in developing the trastuzumab predictive response diagnostic kit. Biodivers...
Guardado en:
Autores principales: | DESRIANI DESRIANI, BUGI RATNO BUDIARTO, WIRSMA ARIF HARAHAP, M. ALI WARISMAN, AUDREY VANIA CLARISSA OMPUSUNGGU, DINA ATHARIAH, FARIDA MIRNAWATI, IDA YUSSRIYANI, FUAD ALAHWANI, AHMAD RIZQI KURNIAWAN |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MBI & UNS Solo
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/29ca8fefc9614933ad16716e51e23f79 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Profile of Trastuzumab Deruxtecan in the Management of Patients with HER2-Positive Unresectable or Metastatic Breast Cancer: An Evidence-Based Review
por: Linehan AS, et al.
Publicado: (2021) -
Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer
por: Rodallec A, et al.
Publicado: (2018) -
Combination of Pertuzumab and Trastuzumab in the Treatment of HER2-Positive Early Breast Cancer: A Review of the Emerging Clinical Data
por: Jagosky M, et al.
Publicado: (2021) -
Functionalized immunostimulating complexes with protein A via lipid vinyl sulfones to deliver cancer drugs to trastuzumab-resistant HER2-overexpressing breast cancer cells
por: Rodríguez-Serrano F, et al.
Publicado: (2016) -
Overexpression of PIK3R1 promotes hepatocellular carcinoma progression
por: Ai,Xuejun, et al.
Publicado: (2018)